Mixed trend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend up since Aug 17 · below the Ichimoku cloud · RSI 46 · MACD below its signal
None of the 29 investors followed here reported a position in CJMB in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CJMB trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 19, 2026 | Croyle David J.Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.75 per share. | 10.2K | $17.84K |
| Mar 5, 2026 | Croyle David J.Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.76 per share. | 14.8K | $26.09K |
| Dec 29, 2025 | Dial GeraldDirector | Purchase at price 1.16 per share. | 10K | $11.60K |
| Dec 29, 2025 | Dial GeraldDirector | Purchase at price 1.20 - 1.22 per share. | 2K | $2.41K |
| Dec 15, 2025 | Williams Wayne DChief Executive Officer | Purchase at price 1.73 per share. | 5K | $8.65K |
| Dec 14, 2025 | Williams Wayne DChief Executive Officer | Purchase at price 1.70 - 1.79 per share. | 15.8K | $27.11K |
| Dec 10, 2025 | Williams Wayne DChief Executive Officer | Purchase at price 1.65 per share. | 44.5K | $73.50K |
| Dec 8, 2025 | Duke Liberty SmithDirector | Purchase at price 1.52 - 1.56 per share. | 1.5K | $2.33K |
| Mar 26, 2025 | Croyle David J.Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.50 per share. | 25K | $112.50K |
| Feb 4, 2025 | Croyle David J.Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.00 per share. | 24.4K | $97.50K |
| Feb 4, 2025 | Williams Wayne DChief Executive Officer | Purchase at price 4.00 per share. | 63.1K | $252.50K |
No analyst coverage for this instrument.
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. In addition, the company engages in oil and gas development business. Callan JMB Inc. has strategic partnership with Alabama State University to advance the United States pharmaceutical manufacturing and supply chain resilience. The company was founded in 2006 and is headquartered in Spring Branch, Texas.